Market Tracker

12/09 5:16pm ET

Inovio Pharmaceuticals Inc (NASDAQ:INO)

7.14
Delayed Data
As of 4:00pm ET
 +0.01 / +0.14%
Today’s Change
4.50
Today|||52-Week Range
11.69
+6.25%
Year-to-Date
Inovio Pharmaceuticals, Inc.'s Biggest Win in 2016
3:14pm / MotleyFool.com - Paid Partner Content
Inovio Pharmaceuticals' Next Zika Opportunity
Dec 01 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close7.13
Today’s open7.18
Day’s range7.10 - 7.38
Volume702,857
Average volume (3 months)1,153,923
Market cap$528.1M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+31.25%
Earnings growth (this year)--
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+288.00%
P/E ratioNM
Price/Sales11.32
Price/Book2.93

Competitors

 Today’s
change
Today’s
% change
SCLNSciClone Pharmaceuti...-0.10-0.97%
OTICOtonomy Inc+0.75+4.31%
RVNCRevance Therapeutics...+0.20+1.16%
LOXOLoxo Oncology Inc+0.26+0.99%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$40.6M
Annual profit (last year)-$29.2M
Net profit margin-71.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
J. Joseph Kim
Chief Operating Officer
Niranjan Y. Sardesai
Corporate headquarters
Plymouth Meeting, Pennsylvania

Forecasts